Holen Sie sich die Stockscreener-App
10.08
0.10%
-0.010
Handel nachbörslich:
10.08
Schlusskurs vom Vortag:
$10.09
Offen:
$10.08
24-Stunden-Volumen:
482
Relative Volume:
0.00
Marktkapitalisierung:
$642.10M
Einnahmen:
-
Nettoeinkommen (Verlust:
$8.58M
KGV:
75.22
EPS:
0.134
Netto-Cashflow:
$-1.11M
1W Leistung:
-0.20%
1M Leistung:
-0.20%
6M Leistung:
+1.20%
1J Leistung:
+0.00%
1-Tages-Spanne:
$10.08
$10.08
1-Wochen-Bereich:
$10.08
$10.10
52-Wochen-Spanne:
$9.87
$10.11
Drugs Made In America Acquisition Ii Corp Stock (DMII) Company Profile
Firmenname
Drugs Made In America Acquisition Ii Corp
Sektor
Branche
Telefon
954-870-3104
Adresse
420 LEXINGTON AVENUE, NEW YORK
Compare DMII vs LION, XXI, UMAC, CCXI
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DMII
Drugs Made In America Acquisition Ii Corp
|
10.08 | 642.73M | 0 | 8.58M | -1.11M | 0.134 |
LION
Lionsgate Studios Corp
|
13.88 | 3.96B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
5.34 | 1.88B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
16.93 | 795.29M | 17.25M | -5.64M | -40.16M | -0.3337 |
CCXI
Churchill Capital Corp Xi
|
14.47 | 813.78M | 0 | 0 | 0 | 0.0647 |
Drugs Made In America Acquisition Ii Corp Aktie (DMII) Neueste Nachrichten
Price to book forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAA - TradingView
Price to sales forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAA - TradingView
Layoff Tracker: EMD Serono may trim R&D workforce by up to 70 - BioSpace
Drugs Made In America Acquisition Corp. Rights (DMAAR) Hold Steady at $0.10 Amid Low ActivityRetail Sentiment - dars.gov.et
Eli Lilly and Co. | Pharmaceuticals, Biomedical Research, & Company - Encyclopedia Britannica
Drugs Made In America Acquisition (NASDAQ:DMAA) Trading Down 0.1%Here's What Happened - MarketBeat
Pfizer Inc. - Encyclopedia Britannica
Price to sales forward of Drugs Made In America Acquisition II Corp. – BOATS:DMIIU - TradingView
Price to earnings forward of Drugs Made In America Acquisition II Corp. – BOATS:DMIIU - TradingView
HSLV Q2 2026 Earnings: Massive EPS Surprise Despite No Reported RevenueCFO Commentary Report - dars.gov.et
Enterprise value to EBIT forward of Drugs Made In America Acquisition II Corp. – BOATS:DMIIU - TradingView
Price to book forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAAU - TradingView
OACCU Stock Fund Price and Chart — NASDAQ:OACCU - TradingView
BRKHU|Burtech Acquisition II Units|Price:10.000|Chg%:-0.10 - TradingKey
Number of shareholders of Drugs Made In America Acquisition Corp. – NASDAQ:DMAAU - TradingView
Drugs Made In America Acquisition Corp. (DMAA) Holds Steady Near Support as SPAC Sector WatchesFRAMA Signal - dars.gov.et
Drugs Made In America Acquisition II Corp. Right (DMIIR) Holds Steady at $0.08 After Minimal UptickEntry Point Alerts - dars.gov.et
DMAADrugs Made In America Acquisition Corp Volatility & Greeks - Finviz
DGICB Q1 2026 Earnings: EPS Misses Estimates by 29.6%, Stock UnchangedHealthcare Earnings Report - dars.gov.et
DMII Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Price to book forward of Drugs Made In America Acquisition II Corp. – NASDAQ:DMII - TradingView
DMAA Holds Steady Near Trust Value as Quiet Trading ContinuesTriangle Correction - dars.gov.et
Price to sales forward of Drugs Made In America Acquisition II Corp. – NASDAQ:DMII - TradingView
Price to book forward of Drugs Made In America Acquisition II Corp. – NASDAQ:DMIIR - TradingView
Price to sales forward of Drugs Made In America Acquisition II Corp. – NASDAQ:DMIIR - TradingView
Feis Equities and Lawrence Feis disclose 5.08% ownership in DMAA (DMAA) - Stock Titan
Price to sales forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAU - TradingView
Enterprise value to revenue forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAU - TradingView
Enterprise value to EBITDA forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAU - TradingView
Price to earnings forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAR - TradingView
Enterprise value to EBITDA forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAR - TradingView
Price to sales forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAR - TradingView
Enterprise value to EBIT forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAR - TradingView
Enterprise value to revenue forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAR - TradingView
Drugs Made In America Acquisition II Units (DMIIU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 - TradingKey
Drugs Made In America Acquisition Corp. (DMAA) Holds Steady Near Resistance as SPAC Sentiment Remains CautiousHedge Fund Exposure - dars.gov.et
Number of shareholders of Drugs Made In America Acquisition II Corp. – NASDAQ:DMIIU - TradingView
Drugs Made In America Acquisition II Corp. Rights (DMIIR) Holds Flat at $0.10 Amid Low ActivityGrowth Factor - dars.gov.et
Drugs Made In America Acquisition Corp (DMAAU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Drugs Made In America Acquisition Corp (DMAAR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAAR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Drugs Made In America Acquisition Corp (DMAAR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Drugs Made In America Acquisition Corp (DMAAU) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAAU) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Drugs Made In America Acquisition Corp (DMAAU) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAAU) Institutional Confidence - TradingKey
Drugs Made In America Acquisition Corp (DMAAR) Institutional Confidence - TradingKey
Drugs Made In America Acquisition Corp - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Drugs Made In America Acquisition Corp (DMAAR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Finanzdaten der Drugs Made In America Acquisition Ii Corp-Aktie (DMII)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.05%
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):